Slender MedicalSlender MedicalUltrasound Without Limits

Confidential2

IntroductionIntroduction

Founded 2007. Headquarters – Herzliya, Israel

Technology: Non-invasive excess-fat removal using high intensity focused ultrasound

Market: Aesthetic market, clinics of plastic surgeons and dermatologists, medical SPAs

Large market opportunity: $8 B

Launch in 2010

Exciting near term exit prospect

Experienced, multi-disciplinary team

Strong IP

Developmental phase: Preclinical phase

Confidential3

Chin LiposuctionChin LiposuctionBefore After

Results obtained by standard liposuction

Confidential4

Large Market OpportunityLarge Market Opportunity

Up to 80% of all women over the age of 20 struggle with excess fat

495,000 potential professional users WW (source: M. Moretti, Medical Insights Inc.)

45,000 dermatologists, plastic surgeons

(150,000 SPA, paramedical)

300,000 other physician specialties (15%)

Estimated end user price $90,000

Total market opportunity: $8 B (Only for the capital part. Consumables will create additional revenue)

Confidential5

Surgical vs. Nonsurgical Surgical vs. Nonsurgical ProceduresProcedures

Liposuction total expenditure:$1.4 B

AAmerican Society for Aesthetic Plastic Surgery, 2007

Confidential6

ProductProduct Ultrasonic elements applied to the

treated area Focused ultrasound for breaking

down adipose tissue Through transmission ultrasound

for monitoring the treatment process

Treatment and monitoring are performed in a closed loop

Ultrasonic transmission is performed parallel to the skin.

Optional several sizes of hand held probe

Short time to market (Launch in 2010)

Confidential7

Technology BenefitsTechnology Benefits

Skin parallel transmission. Safer

avoiding bone pain

preventing transmission of acoustic energy to internal organs

Ability to treat organs that cannot be treated by the competitors (chin and arms)

Temperature feedback. Higher efficacy & Safer

Tissue (muscle/fat) differentiation. Safer

Several probe designs allowing treatment of both large and small areas such as chin and arms. More treatment opportunities for the physician

Confidential8

TeamTeam Dr. Liat Tsoref, Founder and CEO

EarlySense – Director of BD; Sunlight Medical (bone assessment ultrasound)- VP R&D; PhD in Physics, TAU

Prof. Haim Azhari, Founder and CTA

Researcher in the Technion

Mr. Gregory Krasnov, R&D Eng.

MSc, Ultrasound specialist, JetGuide Ltd., Technion

Yossi Gross, Founder and Consultant

Serial entrepreneur (VisionCare, BioControl, TransPharma, BrainsGate, Beta-O2 etc.)

Dr. Amiram Borenstein, Consultant

MD, MSc, Plastic and Aesthetic Surgeon

Confidential9

Objective - InvestmentObjective - Investment

Investment to date:

Rainbow Medical Ltd: $ 1,000,000

"A" Round Target $ 2M

A-Round UOP Clinical study, phase I and II

Development of a beta prototype

CE clearance

Confidential10

SummarySummary

Body shaping is a promising market with very high growth potential

Short time to market – LAUNCH in 2010

Multidisciplinary team with many years of experience in the field of ultrasound

A unique and proprietary technology

The combination of focused ultrasound treatment and monitoring abilities will turn Slender Medical into a leader in the body shaping market